Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Delivery methods of PDT will support our development TLD1433

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Aug 21, 2022 5:24pm

210 Views

Post# 34910257

RE:RE:Delivery methods of PDT will support our development TLD1433

After reading your post Pandora i would argue the safety factor, low doses, low number of treatments makes TLD1433 a far superior treatment plus we have great results so far in phase2 study and we will be looking at BTD in very near future, im biased along with you, big week coming up

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks